Literature DB >> 17183066

Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice.

Insook Kim1, Keiichirou Morimura, Yatrik Shah, Qian Yang, Jerrold M Ward, Frank J Gonzalez.   

Abstract

The farnesoid X receptor (FXR) controls the synthesis and transport of bile acids (BAs). Mice lacking expression of FXR, designated Fxr-null, have elevated levels of serum and hepatic BAs and an increase in BA pool size. Surprisingly, at 12 months of age, male and female Fxr-null mice had a high incidence of degenerative hepatic lesions, altered cell foci and liver tumors including hepatocellular adenoma, carcinoma and hepatocholangiocellular carcinoma, the latter of which is rarely observed in mice. At 3 months, Fxr-null mice had increased expression of the proinflammatory cytokine IL-1beta mRNA and elevated beta-catenin and its target gene c-myc. They also had increased cell proliferation as revealed by increased PCNA mRNA and BrdU incorporation. These studies reveal a potential role for FXR and BAs in hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17183066      PMCID: PMC1858639          DOI: 10.1093/carcin/bgl249

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  36 in total

1.  Evaluation of bromodeoxyuridine labeling in hepatomegaly produced by peroxisomal proliferation or P-450 induction in rodents.

Authors:  P F Smith; K A O'Brien; K P Keenan
Journal:  Prog Clin Biol Res       Date:  1991

2.  Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.

Authors:  Wilfried Bursch; Monika Chabicovsky; Ute Wastl; Bettina Grasl-Kraupp; Krystina Bukowska; Henryk Taper; Rolf Schulte-Hermann
Journal:  Toxicol Sci       Date:  2005-02-23       Impact factor: 4.849

Review 3.  Levels of IL-1 beta control stimulatory/inhibitory growth of cancer cells.

Authors:  Deodutta Roy; Shubhashish Sarkar; Quentin Felty
Journal:  Front Biosci       Date:  2006-01-01

4.  Neoplastic and nonneoplastic lesions in aging (C57BL/6N x C3H/HeN)F1 (B6C3F1) mice.

Authors:  J M Ward; D G Goodman; R A Squire; K C Chu; M S Linhart
Journal:  J Natl Cancer Inst       Date:  1979-09       Impact factor: 13.506

5.  Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor.

Authors:  Gianluca Svegliati-Baroni; Francesco Ridolfi; Rebekka Hannivoort; Stefania Saccomanno; Manon Homan; Samuele De Minicis; Peter L M Jansen; Cinzia Candelaresi; Antonio Benedetti; Han Moshage
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

6.  Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness.

Authors:  Rama Pai; Andrzej S Tarnawski; Teresa Tran
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

7.  Molecular cloning and regulated expression of the human c-myc gene in Escherichia coli and Saccharomyces cerevisiae: comparison of the protein products.

Authors:  C Miyamoto; R Chizzonite; R Crowl; K Rupprecht; R Kramer; M Schaber; G Kumar; M Poonian; G Ju
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

Review 8.  Endocrine functions of bile acids.

Authors:  Sander M Houten; Mitsuhiro Watanabe; Johan Auwerx
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

9.  Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.

Authors:  Yaping Liu; Jane Binz; Mary Jo Numerick; Steve Dennis; Guizhen Luo; Bhasha Desai; Kathleen I MacKenzie; Traci A Mansfield; Steven A Kliewer; Bryan Goodwin; Stacey A Jones
Journal:  J Clin Invest       Date:  2003-11-17       Impact factor: 14.808

10.  Bile duct-specific lectins, Dolichos biflorus agglutinin and peanut agglutinin, as probes in mouse hepatocarcinogenesis.

Authors:  K Takahashi; C J Viviano; M R Elwell; W E Bakewell; M Kuwahara; N Nakashima; B N Blackwell; R R Maronpot
Journal:  Lab Invest       Date:  1995-09       Impact factor: 5.662

View more
  150 in total

Review 1.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine.

Authors:  Matthew J Potthoff; Steven A Kliewer; David J Mangelsdorf
Journal:  Genes Dev       Date:  2012-02-02       Impact factor: 11.361

2.  Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.

Authors:  Zhipeng Meng; Xiaoqiong Wang; Yichao Gan; Yunfeng Zhang; Hong Zhou; Carl Van Ness; Jun Wu; Guiyu Lou; Hua Yu; Chao He; Rongzhen Xu; Wendong Huang
Journal:  J Hepatol       Date:  2012-06-21       Impact factor: 25.083

3.  Microbial Metabolites as Molecular Mediators of Host-Microbe Symbiosis in Colorectal Cancer.

Authors:  N P Hyland; A Houston; J M Keane; S A Joyce; C G M Gahan
Journal:  Results Probl Cell Differ       Date:  2020

4.  Chronic activation of FXR-induced liver growth with tissue-specific targeting Cyclin D1.

Authors:  Weibin Wu; Qing Wu; Xinmei Liu
Journal:  Cell Cycle       Date:  2019-06-25       Impact factor: 4.534

Review 5.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 6.  Bile acids are nutrient signaling hormones.

Authors:  Huiping Zhou; Phillip B Hylemon
Journal:  Steroids       Date:  2014-05-10       Impact factor: 2.668

7.  Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.

Authors:  Yan-Dong Wang; Wei-Dong Chen; Cunbao Li; Cong Guo; Yanyan Li; Hui Qi; Hailing Shen; Jing Kong; Xuecheng Long; Frank Yuan; Xichun Wang; Wendong Huang
Journal:  Mol Endocrinol       Date:  2014-12-12

8.  Mechanisms of STAT3 activation in the liver of FXR knockout mice.

Authors:  Guodong Li; Yan Zhu; Ossama Tawfik; Bo Kong; Jessica A Williams; Le Zhan; Karen M Kassel; James P Luyendyk; Li Wang; Grace L Guo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-03       Impact factor: 4.052

9.  Bile Acid Receptors and Liver Cancer.

Authors:  Xichun Wang; Xianghui Fu; Carl Van Ness; Zhipeng Meng; Xiaoxiao Ma; Wendong Huang
Journal:  Curr Pathobiol Rep       Date:  2012-12-21

Review 10.  Med1 subunit of the mediator complex in nuclear receptor-regulated energy metabolism, liver regeneration, and hepatocarcinogenesis.

Authors:  Yuzhi Jia; Navin Viswakarma; Janardan K Reddy
Journal:  Gene Expr       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.